8.3 Antibody Formats and Titration

8.3 Antibody Formats and Titration

Quick Answer: Concentrates are diluted locally. Prediluted/RTU vials are already at a working concentration for a stated method. Lyophilized antibodies are reconstituted with a specified diluent and volume, then titered. The working titer is the highest dilution that still gives the strongest specific stain with the least background. Serial dilutions beat guessing. RTU does not skip verification. Clone ≠ lot.

This OpenExamPrep section is independent teaching on antibody formats and titration covering published QIHC staining-reagent topic areas. It is not an ASCP publication and does not claim Board, CAP, or vendor approval.

Concentrated, prediluted, and lyophilized

Laboratories do not all receive the same physical antibody.

Concentrated (stock) antibody arrives as a liquid at a high protein concentration (often in the milligram-per-milliliter class, or as a vendor "concentrate" without a µg/mL on the label). You prepare a working dilution in antibody diluent (Section 8.4). Advantages: cost per slide once titered, ability to match incubation time and detection chemistry, ability to run a true serial titration. Risks: pipetting error, wrong diluent, microbial growth in a working bottle left on the bench, and a homemade dilution that nobody documented.

Prediluted or ready-to-use (RTU) antibody is already at a working concentration, often matched to a closed autostainer protocol (retrieval, volume, time, temperature, polymer). Advantages: fewer dilution mistakes, vendor-optimized starting point. Risks: treating the bottle as universally valid on a different stainer, a different retrieval, or a different detection polymer; pooling leftover RTU into a concentrate bottle; assuming "ready" means "already verified on our tissues."

Lyophilized antibody is freeze-dried for shipping and storage stability. It is not a working stain until reconstitution. Typical reconstitution rules:

• Add exactly the volume of specified diluent (often distilled or deionized water, sometimes a provided buffer)—not tap water, not leftover PBS from a wash jug, not "about 1 mL."
• Dissolve gently. Do not vortex on high for minutes; foaming denatures protein. Invert or roll until clear, then allow a short rest if the insert says so.
• Record date, time, diluent, volume, and resulting stock concentration. The clock on reconstituted stability starts now, not on the lyophilized expiry printed for the dry cake.
• Aliquot if the insert allows; avoid repeated freeze-thaw of the reconstituted stock.
• Only after you have a defined stock do you make working dilutions for titration.

A partially reconstituted cake with undissolved flakes is not a 1:200 working antibody. A lyophilized vial reconstituted to twice the specified volume is a different stock concentration; every later "1:200" is wrong.

The correct titer

Classic histotechnology wording, which QIHC-style stems still use: the optimal working titer is the highest dilution of antibody that produces the strongest specific staining with the least background.

Unpack that. Highest dilution means more dilute (1:400 is a higher dilution than 1:50). You are looking for the leanest antibody concentration that still fully labels the expected compartment in the positive control and in the intended patient tissue class, without painting stroma, serum, or the wrong compartment. A 1:20 that is coal-black on tumor and dirty on collagen is not "stronger therefore better." A 1:1600 that is clean but only faint on a known high-expressor is too dilute.

Signal-to-noise, not absolute darkness, is the score. Polyclonal concentrates often need more dilution care because extra specificities raise background as concentration rises. Monoclonals can still dirty a slide if the titer is too strong, retrieval is too harsh, or the detection polymer is universal and leftover Ig remains.

Vendor inserts give a starting range (for example 1:100–1:200, or 1 µg/mL). That range is not the laboratory's validated titer until tissues, fixation, retrieval, detection, and incubation match what you will use clinically.

Serial dilutions

Do not jump from neat concentrate to a single guessed 1:250. Hold retrieval, detection, time, and temperature constant and vary only antibody concentration.

A practical series around a vendor suggestion of 1:200:

• 1:50, 1:100, 1:200, 1:400, 1:800 (two-fold steps)

Read matched slides:

• Known positive tissue with the expected compartment (nuclear, cytoplasmic, membranous).
• Known negative or low-expressor tissue of similar fixation.
• Omit-primary (diluent only) to see detection stick.

What you should see as you dilute: background falls; specific stain remains until a cliff, then fades. The working titer is the most dilute slide that still shows complete, crisp specific labeling—not the first slide that is merely "visible." If 1:200 and 1:400 look identical on specific stain but 1:200 has stromal blush, 1:400 wins. If 1:400 loses the weak internal control (normal breast ducts for a cytokeratin, or a low-expressor control for a predictive marker), you may need 1:200—or you may need better retrieval, not more antibody.

Titrate one variable at a time. Changing HIER pH in the same experiment as the dilution series confounds the titer. Changing from 32 °C onboard for 16 minutes to overnight at 4 °C is a different method (Section 8.4); retiter if you change incubation.

Document the titer as dilution plus method: "1:400, rabbit mAb clone X, polymer detection, high-pH HIER, 32 °C 16 min." A dilution without the rest of the recipe is not reproducible.

RTU kits still need verification

Ready-to-use is ready relative to the vendor's stated protocol, not relative to the laws of immunohistochemistry. Verification (and, when it is a laboratory-developed or modified method, analytic validation) asks: on this laboratory's fixation, processing, retrieval, stainer, and reader, does the RTU produce the expected pattern on positive and negative tissues?

You still check:

• Expected compartment and intensity on on-slide or run controls.
• A negative tissue or negative reagent control.
• Lot-to-lot behavior when a new RTU lot arrives.
• That nobody diluted the RTU "to save money" or concentrated it "because yesterday was weak."

If you dilute an RTU, you have created a new concentrate-style method and you own the titration. If you move an RTU bottle from vendor protocol A (citrate, 20 minutes, polymer Y) to protocol B (EDTA, 32 minutes, a different polymer), you have a new method. CAP analytic-validation practice for IHC (Goldsmith 2024 summary) treats method changes as validation events; the staining-bench point is that the plastic RTU dropper is not a substitute for those checks. Full 10+10 / 20+20 numbers belong in the laboratory-operations chapter; here, remember RTU ≠ skip verification.

Clone versus lot

Clone is the antibody identity (for monoclonals: the hybridoma or recombinant clone name; for polyclonals: the serum product). Changing clone—mouse SP1-class ER to a different ER clone, or CK AE1/AE3 to CK OSCAR—is a different primary. Sensitivity, background, retrieval needs, and clinical cutoffs can all move. That is a full revalidation event in CAP analytic-validation practice, not a titer copy-paste.

Lot is one manufacturing batch of the same clone (or same polyclonal product). Protein concentration and minor impurities can shift. CAP 2024 Goldsmith summary uses a limited new-lot check (1 positive + 1 negative) for the same antibody lot change, distinct from a clone change. Do not mix leftover lot A and lot B in one working bottle to "use it up." Do not assume lot B is 1:400 because lot A was 1:400 until you compare controls.

Polyclonal "lots" are even less interchangeable than monoclonal lots because each bleed can differ. Treat a new polyclonal lot as needing at least the lot check, and watch background.

Worked example

Vendor concentrate suggests 1:100–1:200. Serial slides at 1:50, 1:100, 1:200, 1:400, 1:800 with locked HIER and polymer: 1:50 is black tumor and dirty fibroblasts; 1:100 is strong tumor with mild stroma; 1:200 is strong, crisp, clean; 1:400 is slightly weaker on the low-expressor control; 1:800 is patchy. Working titer is 1:200—the highest dilution that still gives the strongest acceptable specific stain with the least background. A new lot of the same clone arrives; you do not skip a control comparison. A colleague wants to switch to a different clone in an RTU dispenser "because it is ready-to-use"; that is a clone change plus a format change, not a verification-free swap. A lyophilized vial reconstituted with 2 mL instead of the specified 1 mL makes every later 1:200 actually 1:400 relative to the insert—specific stain fades and someone "fixes" it by doubling incubation instead of admitting the reconstitution error.